159 related articles for article (PubMed ID: 23378737)
1. Intravitreal bevacizumab combined with plaque brachytherapy reduces melanoma tumor volume and enhances resolution of exudative detachment.
Houston SK; Shah NV; Decatur C; Lonngi M; Feuer W; Markoe AM; Murray TG
Clin Ophthalmol; 2013; 7():193-8. PubMed ID: 23378737
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal triamcinolone versus intravitreal bevacizumab in the treatment of exudative retinal detachment secondary to posterior uveal melanoma.
Parrozzani R; Pilotto E; Dario A; Miglionico G; Midena E
Am J Ophthalmol; 2013 Jan; 155(1):127-133.e2. PubMed ID: 22995029
[TBL] [Abstract][Full Text] [Related]
3. Systemic bevacizumab (Avastin) for exudative retinal detachment secondary to choroidal melanoma.
Newman H; Finger PT; Chin KJ; Pavlick AC
Eur J Ophthalmol; 2011; 21(6):796-801. PubMed ID: 21445839
[TBL] [Abstract][Full Text] [Related]
4. Management of exudative retinal detachment in choroidal melanoma.
Gibran SK; Kapoor KG
Clin Exp Ophthalmol; 2009 Sep; 37(7):654-9. PubMed ID: 19788660
[TBL] [Abstract][Full Text] [Related]
5. Regression patterns of choroidal melanoma: After palladium-103 (
Maheshwari A; Finger PT
Eur J Ophthalmol; 2018 Nov; 28(6):722-730. PubMed ID: 29788760
[TBL] [Abstract][Full Text] [Related]
6. Subfoveal choroidal melanoma: pretreatment characteristics and response to plaque radiation therapy.
Newman H; Chin KJ; Finger PT
Arch Ophthalmol; 2011 Jul; 129(7):892-8. PubMed ID: 21746980
[TBL] [Abstract][Full Text] [Related]
7. Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16.
Melia BM; Abramson DH; Albert DM; Boldt HC; Earle JD; Hanson WF; Montague P; Moy CS; Schachat AP; Simpson ER; Straatsma BR; Vine AK; Weingeist TA;
Ophthalmology; 2001 Feb; 108(2):348-66. PubMed ID: 11158813
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal triamcinolone acetate for radiation maculopathy recalcitrant to high-dose intravitreal bevacizumab.
Kaplan RI; Chaugule SS; Finger PT
Br J Ophthalmol; 2017 Dec; 101(12):1694-1698. PubMed ID: 28416492
[TBL] [Abstract][Full Text] [Related]
9. Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results.
Kokame GT; Lai JC; Wee R; Yanagihara R; Shantha JG; Ayabe J; Hirai K
BMC Ophthalmol; 2016 Jul; 16():127. PubMed ID: 27465105
[TBL] [Abstract][Full Text] [Related]
10. A five-year study of slotted eye plaque radiation therapy for choroidal melanoma: near, touching, or surrounding the optic nerve.
Finger PT; Chin KJ; Tena LB
Ophthalmology; 2012 Feb; 119(2):415-22. PubMed ID: 22133796
[TBL] [Abstract][Full Text] [Related]
11. Multi-year follow-up of fine-needle aspiration biopsy in choroidal melanoma.
McCannel TA; Chang MY; Burgess BL
Ophthalmology; 2012 Mar; 119(3):606-10. PubMed ID: 22226884
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal triamcinolone acetonide for acute radiation papillopathy.
Shields CL; Demirci H; Marr BP; Mashayekhi A; Dai VV; Materin MA; Shields JA
Retina; 2006; 26(5):537-44. PubMed ID: 16770260
[TBL] [Abstract][Full Text] [Related]
13. [Exudative retinal detachment surgery. A prognostic++ parameter of malignant melanoma in brachytherapy?].
Brieden SR; Schmidt J; Kroll P
Ophthalmologe; 1999 Jan; 96(1):1-5. PubMed ID: 10067326
[TBL] [Abstract][Full Text] [Related]
14. Management of diffuse choroidal hemangioma in Sturge-Weber syndrome with Ruthenium-106 plaque radiotherapy.
Kubicka-Trząska A; Karska-Basta I; Oleksy P; Romanowska-Dixon B
Graefes Arch Clin Exp Ophthalmol; 2015 Nov; 253(11):2015-9. PubMed ID: 26004077
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C
J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687
[TBL] [Abstract][Full Text] [Related]
16. Ruthenium-106 (
Bajpai V; Raval V; Reddy P VA; Kaliki S
Eur J Ophthalmol; 2024 May; ():11206721241257974. PubMed ID: 38794917
[TBL] [Abstract][Full Text] [Related]
17. Rate of resolution of exudative retinal detachment after plaque radiotherapy for uveal melanoma.
Harbour JW; Ahmad S; El-Bash M
Arch Ophthalmol; 2002 Nov; 120(11):1463-9. PubMed ID: 12427058
[TBL] [Abstract][Full Text] [Related]
18. Bilateral simultaneous primary choroidal melanomas: Treated with palladium-103 plaque radiation.
Maheshwari A; Finger PT
Eur J Ophthalmol; 2018 Sep; 28(5):NP1-NP5. PubMed ID: 29575936
[TBL] [Abstract][Full Text] [Related]
19. Palladium-103 plaque radiation therapy for American Joint Committee on cancer T3- and T4-staged choroidal melanomas.
Semenova E; Finger PT
JAMA Ophthalmol; 2014 Feb; 132(2):205-13. PubMed ID: 24287555
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal dexamethasone implant (Ozurdex®) for exudative retinal detachment after proton beam therapy for choroidal melanoma.
Malclès A; Nguyen AM; Mathis T; Grange JD; Kodjikian L
Eur J Ophthalmol; 2017 Aug; 27(5):596-600. PubMed ID: 28218368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
